Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence

Pancreatic ductal adenocarcinoma (PDAC) is an extraordinarily lethal disease, which, despite a more or less efficient chemotherapeutic treatment, systematically displays a rapid and uncontrolled progression towards a fatal recurrence. Determining which cells give rise to such tumor recurrence is thu...

Descripción completa

Detalles Bibliográficos
Autores principales: Molejon, Maria Inés, Tellechea, Juan Ignacio, Moutardier, Vincent, Gasmi, Mohamed, Ouaissi, Mehdi, Turrini, Olivier, Delpero, Jean-Robert, Dusetti, Nelson, Iovanna, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506359/
https://www.ncbi.nlm.nih.gov/pubmed/26244163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506359/
https://www.ncbi.nlm.nih.gov/pubmed/26244163

Ejemplares similares